| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2022―Apr―10 |
Should routine risk reduction procedures for the prevention and control of pandemics become a standard in all oncological outpatient clinics? The prospective COVID-19 cohort study: protect-CoV |
Theres Fey, Nicole Erickson, Arndt Stahler, Maximilian Muenchhoff, Oliver T. Keppler, Katharina Ruehlmann, et al. (+13) Gabriele Krauss-Pfeiffer, Hannah Steinberg, Alexander Graf, Stefan Krebs, Helmut Blum, Elham Khatamzas, Sarah Seynstahl, Jozefina Casuscelli, Daniel Markwardt, Roswitha Forstpointner, Timo Schinköthe, Michael von Bergwelt-Baildon, Volker Heinemann |
| 2 |
[GO] |
2022―Feb―23 |
How to ensure uninterrupted treatment of radiotherapy patients during delta variants of SARS-CoV-2 virus epidemic: the latest experience from Xi’an, China |
Yongkai Lu, Ruijuan Chen, Yi Li |
| 3 |
[GO] |
2022―Jan―20 |
SARS-CoV-2 spike protein inhibits growth of prostate cancer: a potential role of the COVID-19 vaccine killing two birds with one stone |
Bradley D. Johnson, Ziwen Zhu, Marco Lequio, Coby G. D. Powers, Qian Bai, Huaping Xiao, et al. (+3) Emerson Fajardo, Mark R. Wakefield, Yujiang Fang |
| 4 |
[GO] |
2021―Nov―08 |
The role of inflammatory indices in the outcome of COVID-19 cancer patients |
Hend A. Nooh, Mona S. Abdellateif, Lobna Refaat, Eman Z. Kandeel, Ahmed Bayoumi, Mohamed Samra, Medhat Khafagy |
| 5 |
[GO] |
2021―Nov―05 |
COVID-19 pandemic: a new cause of unplanned interruption of radiotherapy in breast cancer patients |
Shiho Lee, Jaesung Heo |
| 6 |
[GO] |
2021―Sep―28 |
The “collateral damage” of the war on COVID-19: impact of the pandemic on the care of epithelial ovarian cancer |
Luxitaa Goenka, Annuja Anandaradje, Tejaeswar Nakka, Smita Kayal, Biswajit Dubashi, Latha Chaturvedula, et al. (+4) Pampapati Veena, Jayalakshmi Durairaj, Prasanth Penumadu, Prasanth Ganesan |
| 7 |
[GO] |
2021―Jul―24 |
Cancer and COVID-19: Why are cancer patients more susceptible to COVID-19? |
Saptarshi Sinha, Chanakya Nath Kundu |
| 8 |
[GO] |
2021―Jul―08 |
Vaccination of cancer patients against COVID-19: towards the end of a dilemma |
Avik Mandal, Pritanjali Singh, Arghadip Samaddar, Dharmendra Singh, Manika Verma, Amrita Rakesh, Rakesh Ranjan |
| 9 |
[GO] |
2021―Jun―30 |
Can the host immune response against SARS-CoV2 also cause an anticancer effect? |
Seda Kahraman, Muhammed Bulent Akinci, Mehmet Ali Nahit Sendur, Bulent Yalcin |
| 10 |
[GO] |
2021―Apr―23 |
The effect of the COVID-19 pandemic on routine adult vaccination in cancer patients |
Nesligul Ozdemir, Aygin Bayraktar-Ekincioglu, Saadettin Kilickap |
| 11 |
[GO] |
2021―Feb―19 |
Major impact of COVID-19 national containment on activities in the French northern comprehensive cancer center |
Nicolas Penel, Ali Hammoudi, Guillaume Marliot, Antoine De Courreges, Malgorzata Cucchi, Xavier Mirabel, et al. (+2) Eric Leblanc, Eric Lartigau |
| 12 |
[GO] |
2020―Nov―04 |
Back to (new) normality-A CODRAL/AIRO-L survey on cancer radiotherapy in Lombardy during Italian COVID-19 phase 2 |
Barbara Alicja Jereczek-Fossa, Matteo Pepa, Giulia Marvaso, Johannes Lars Isaksson, Carlo Pietro Soatti, Luigi Franco Cazzaniga, et al. (+31) Giovanni Battista Ivaldi, Marcello Amadori, Paolo Antognoni, Stefano Arcangeli, Alberto Buffoli, Giancarlo Beltramo, Mario Bignardi, Stefano Bracelli, Lorenza Bruschieri, Simona Castiglioni, Gianpiero Catalano, Nadia Di Muzio, Carlo Fallai, Laura Fariselli, Andrea Riccardo Filippi, Alberto Gramaglia, Corrado Italia, Fabrizio Lombardi, Stefano Maria Magrini, Simonetta Nava, Ester Orlandi, Nadia Pasinetti, Elena Lara Sbicego, Luciano Scandolaro, Marta Scorsetti, Francesco Stiglich, Roberto Tortini, Riccardo Valdagni, Vittorio Vavassori, Sandro Tonoli, Mauro Filippo Palazzi |
| 13 |
[GO] |
2020―Aug―24 |
Questions asked through two examples of dilemmas of publication ethics in the process of COVID-19 |
Ozgur Tanriverdi, Muesser Ozcan |
| 14 |
[GO] |
2020―Aug―17 |
Head and neck radiotherapy amid the COVID-19 pandemic: practice recommendations of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) |
Daniela Alterio, Stefania Volpe, Almalina Bacigalupo, Pierluigi Bonomo, Francesca De Felice, Francesco Dionisi, et al. (+20) Ida D’Onofrio, Elisa D’Angelo, Alessia Di Rito, Giuseppe Fanetti, Pierfrancesco Franco, Marta Maddalo, Anna Merlotti, Francesco Micciché, Ester Orlandi, Fabiola Paiar, Stefano Ursino, Matteo Pepa, Renzo Corvò, Nadia Gisella Di Muzio, Stefano Maria Magrini, Elvio Russi, Giuseppe Sanguineti, Barbara Alicja Jereczek-Fossa, Vittorio Donato, Daniela Musio |
| 15 |
[GO] |
2020―Aug―09 |
Providing optimal interventional oncology procedures at one of the COVID-19 referral center in Italy |
Filippo Pesapane, Anna Maria Ierardi, Antonio Arrichiello, Gianpaolo Carrafiello |
| 16 |
[GO] |
2020―Aug―07 |
COVID-19 and cancer care: what do international guidelines say? |
Alfredo Tartarone, Rosa Lerose |
| 17 |
[GO] |
2020―Aug―03 |
Considerations in treating patients with advance lung cancer during the epidemic outbreak of novel coronavirus (SARS-CoV-2) |
Yangyang Cai, Yinghui Xu, Dongsheng Xu, Yizhuo Wang, Xu Wang, Chao Sun, et al. (+3) Ye Guo, Shi Qiu, Kewei Ma |
| 18 |
[GO] |
2020―Jul―29 |
What to do in an oncology department to face the new COVID-19 era challenges? |
S. K. Garattini, A. Bin, R. Donato, M. Mansutti, S. Rizzato, G. Troiero, et al. (+3) A. Candoni, R. Fanin, G. Fasola |
| 19 |
[GO] |
2020―May―29 |
Cancer patients in COVID-19 outbreak: something more than Suram fortress |
Daris Ferrari, Martina Violati, Carla Codecà |
| 20 |
[GO] |
2020―May―29 |
Cancer treatment during COVID-19 pandemic |
Vishal Jindal, Kamal Kant Sahu, Susanna Gaikazian, Ahmad Daniyal Siddiqui, Ishmael Jaiyesimi |
| 21 |
[GO] |
2020―Apr―24 |
Lymphopenia that may develop in patients treated with temozolomide and immune control check-point inhibitor may be a high risk for mortality during the COVID-19 outbreak |
Ozgur Tanriverdi |
|
